{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:10:18Z","timestamp":1789517418979,"version":"build-2803163510"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1097\/01.ico.0000170693.13326.fb","type":"journal-article","created":{"date-parts":[[2006,3,9]],"date-time":"2006-03-09T17:09:56Z","timestamp":1141924196000},"page":"199-202","source":"Crossref","is-referenced-by-count":90,"title":["Adenoviral Keratoconjunctivitis in a Tertiary Care Eye Clinic"],"prefix":"10.1097","volume":"25","author":[{"given":"Amir Latif","family":"Butt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Chodosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210204","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3181\/00379727-84-20714","article-title":"Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture.","volume":"84","author":"Rowe","year":"1953","journal-title":"Proc Soc Exp Biol Med"},{"key":"R3-15-20210204","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1128\/JCM.37.12.3940-3945.1999","article-title":"Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively.","volume":"37","author":"De Jong","year":"1999","journal-title":"J Clin Microbiol"},{"key":"R5-15-20210204","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0002-9394(98)00224-4","article-title":"Photorefractive keratectomy for myopia in the setting of adenoviral subepithelial infiltrates.","volume":"126","author":"Fite","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"R6-15-20210204","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/oxfordjournals.epirev.a036304","article-title":"Epidemiology of epidemic keratoconjunctivitis.","volume":"9","author":"Ford","year":"1987","journal-title":"Epidemiol Rev"},{"key":"R7-15-20210204","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1056\/NEJM196305092681902","article-title":"Infections due to adenovirus type 8 in the United States. II. Community-wide infection with adenovirus type 8.","volume":"268","author":"Dawson","year":"1963","journal-title":"N Engl J Med"},{"key":"R8-15-20210204","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0161-6420(90)32389-8","article-title":"Prolonged recoverability of desiccated adenovirus type 19 from various surfaces.","volume":"97","author":"Nauheim","year":"1990","journal-title":"Ophthalmology"},{"key":"R9-15-20210204","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0161-6420(93)31389-8","article-title":"Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro.","volume":"100","author":"Gordon","year":"1993","journal-title":"Ophthalmology"},{"key":"R10-15-20210204","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/bmj.1.5126.873","article-title":"The story of the shipyard eye.","volume":"1","author":"Jawetz","year":"1959","journal-title":"BMJ"},{"key":"R11-15-20210204","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archopht.1996.01100130573014","article-title":"The effects of corticosteroids on adenoviral replication.","volume":"114","author":"Romanowski","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"R12-15-20210204","first-page":"253","article-title":"Topical corticosteroids reverse the antiviral effect of topical cidofovir in the Ad5-inoculated New Zealand rabbit ocular model.","volume":"38","author":"Romanowski","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-15-20210204","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00003226-200108000-00020","article-title":"Short-term treatment with a potent topical corticosteroid of an acute ocular adenoviral infection in the New Zealand White rabbit.","volume":"20","author":"Romanowski","year":"2001","journal-title":"Cornea"},{"key":"R14-15-20210204","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00003226-200204000-00010","article-title":"Topical corticosteroids of limited potency promote adenovirus replication in the Ad5\/NZW rabbit ocular model.","volume":"21","author":"Romanowski","year":"2002","journal-title":"Cornea"},{"key":"R15-15-20210204","first-page":"13","article-title":"The clinical features of viral keratitis and a concept of their pathogenesis.","volume":"51","author":"Jones","year":"1958","journal-title":"Proc R Soc Med"},{"key":"R16-15-20210204","first-page":"783","article-title":"Adenovirus keratitis: a role for interleukin-8.","volume":"41","author":"Chodosh","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-15-20210204","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.4049\/jimmunol.170.12.6234","article-title":"c-Src activation induces early IL-8 expression in adenovirus-infected human corneal fibroblasts.","volume":"170","author":"Natajaran","year":"2003","journal-title":"J Immunol"},{"key":"R18-15-20210204","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1055\/s-2008-1057579","article-title":"Die wirkung von steroiden bei keratoconjunctivitis epidemica.","volume":"176","author":"Trauzettel-Klosinski","year":"1980","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"R19-15-20210204","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archopht.1970.00990040038010","article-title":"Corneal infiltrates in epidemic keratoconjunctivitis.","volume":"84","author":"Laibson","year":"1970","journal-title":"Arch Ophthalmol"},{"key":"R20-15-20210204","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archopht.119.10.1487","article-title":"Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.","volume":"119","author":"Hillenkamp","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R21-15-20210204","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0161-6420(02)00992-2","article-title":"The effects of cidofovir 1% with and without cyclosporin A 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.","volume":"109","author":"Hillenkamp","year":"2002","journal-title":"Ophthalmology"},{"key":"R22-15-20210204","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-2008-1035037","article-title":"Local cyclosporin A therapy of nummuli after epidemic keratoconjunctivitis-a case report.","volume":"210","author":"Reinhard","year":"1997","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"R23-15-20210204","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.ico.0000127481.23714.b6","article-title":"Topical cyclosporine A inhibits subepithelial immune infiltrates but also promotes viral shedding in experimental adenovirus models.","volume":"24","author":"Romanowski","year":"2005","journal-title":"Cornea"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003226-200602000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:09:35Z","timestamp":1785856175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-200602000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.ico.0000170693.13326.fb","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}